Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline Absorption in Pediatric Nasal and Dental Surgery
NCT02062996Phase 2Withdrawn
- Start
- Jun 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxymetazoline in sinusitis, Turbinate hypertrophy and dental caries (5 arms). Primary endpoint: Oxymetazoline plasma concentration. Planned start Jun 2014; status: withdrawn.
02
Drugs
oxymetazoline
03
Conditions
sinusitisTurbinate hypertrophydental caries
Beyond the preview
Go deeper on NCT02062996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062996.